Related Experiment Video
Updated: Oct 11, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Somatic mitochondrial DNA mutations in different grades of glioma
Bee Hong Soon1,2, Nadiah Abu1, Nor Azian Abdul Murad1
1UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Abstract:
Aim: Mitochondrial DNA (mtDNA) alterations play an important role in the multistep processes of cancer development. Gliomas are among the most diagnosed brain cancer. The relationship between mtDNA alterations and different grades of gliomas are still elusive. This study aimed to elucidate the profile of somatic mtDNA mutations in different grades of gliomas and correlate it with clinical phenotype. Materials & methods: Forty histopathologically confirmed glioma tissue samples and their matched blood were collected and subjected for mtDNA sequencing. Results & conclusion: About 75% of the gliomas harbored at least one somatic mutation in the mtDNA gene, and 45% of these mutations were pathogenic. Mutations were scattered across the mtDNA genome, and the commonest nonsynonymous mutations were located at complex I and IV of the mitochondrial respiratory chain. These findings may have implication for future research to determine the mitochondrial energetics and its downstream metabolomics on gliomas.
Insights
Mitochondrial DNA (mtDNA) mutations are common in brain gliomas, with 45% being pathogenic. These findings offer insights into cancer development and potential therapeutic targets.
Area of Science:
- Oncology
- Genetics
- Neuroscience
Background:
- Mitochondrial DNA (mtDNA) alterations are implicated in cancer development.
- Gliomas are a common type of brain cancer, but the role of mtDNA alterations in their progression is not fully understood.
Purpose of the Study:
- To investigate the profile of somatic mtDNA mutations across different grades of gliomas.
- To correlate these mtDNA alterations with the clinical characteristics of glioma patients.
Main Methods:
- Sequencing of mitochondrial DNA (mtDNA) from 40 glioma tissue samples and matched blood.
- Histopathological confirmation of all glioma samples.
Main Results:
- Somatic mtDNA mutations were identified in approximately 75% of gliomas.
- 45% of the detected mtDNA mutations were classified as pathogenic.
- Mutations were distributed throughout the mtDNA genome, frequently affecting genes in mitochondrial respiratory chain complexes I and IV.
Conclusions:
- Somatic mtDNA mutations are prevalent in gliomas and can be pathogenic.
- The identified mutation patterns may influence mitochondrial function and cellular metabolism in gliomas.
- Further research into mitochondrial energetics and metabolomics in gliomas is warranted.
Related Concept Videos
Mutations
Animal Mitochondrial Genetics
Cancers Originate from Somatic Mutations in a Single Cell

